Eric Bunting, MD
Otolaryngology · Wichita, KSNPI 1952302341
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,812 of the $8,776 with a category attached, or 77.6%. Intersect ENT, Inc. accounts for 63.8% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $4,220 and has fallen 90.6% since, to $396 in 2025.
Across 149 payments — averaging $58.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$6K
- Medtronic$590
- Inspire Medical Systems, Inc.$423
- Aerin Medical Inc.$408
- GSK$273
- Stryker$267
- plus $1K from 23 others
What the payments were for
- Travel & lodging$1,87721%
- Food & beverage$6,81278%
- Education$871%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 43 | $5,596 |
| Medtronic | 8 | $590 |
| Inspire Medical Systems, Inc. | 16 | $423 |
| Aerin Medical Inc. | 12 | $408 |
| GSK | 14 | $273 |
| Stryker | 8 | $267 |
| Integra Lifesciences Corporation | 4 | $188 |
| Hologic Sales And Service, LLC | 3 | $182 |
| Acclarent, Inc | 6 | $135 |
| Optinose US, Inc. | 7 | $88 |
| Vertex | 2 | $64 |
| Amgen | 2 | $62 |
| Sanofi-aventis U.S. LLC | 1 | $53 |
| Olympus America Inc. | 2 | $50 |
| Johnson & Johnson | 2 | $49 |
| Kaleo, Inc. | 3 | $39 |
| Smith+Nephew | 2 | $37 |
| Greer Laboratories, Inc. | 2 | $36 |
| Innovation Technologies Inc | 2 | $32 |
| Neurent Medical Limited | 1 | $31 |
| Apria Healthcare LLC | 1 | $31 |
| Davol Inc. | 1 | $24 |
| Avanos Medical | 1 | $22 |
| Sanofi | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Novartis | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Alk-abello, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$3,529
- SINUVA$3,470
- Inspire$137
- Vivaer RF Stylus$130
- VIVAER STYLUS$123
- RHINAER STYLUS$123
- Acclarent Aera$106
- Inspira Air$106
- TruDi Probe$106
How this compares
$8,776 in reported general payments places this provider in the 85th percentile of 87 otolaryngology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucalaMepolizumab | 13 | $45,564 |
| Epinephrine | 34 | $5,040 |
| Pantoprazole Sodium | 548 | $4,056 |
| Azelastine Hcl | 175 | $3,893 |
| Dexamethasone Sodium Phosphate | 47 | $2,779 |
| Famotidine | 300 | $2,010 |
| Omeprazole | 217 | $1,584 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 161 | $1,579 |
| Fluticasone Propionate | 85 | $1,463 |
| Ofloxacin | 63 | $1,318 |
| Ipratropium Bromide | 43 | $1,066 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 91 | $958 |
| Cefdinir | 48 | $867 |
| Doxycycline Hyclate | 48 | $734 |
| Calcitriol | 35 | $721 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKNucala | $273 | $45,56413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 87 otolaryngology providers in Kansas.
Other otolaryngology in Wichita
- Phong leWichita$4K
- Gabriel de la GarzaWichita$4K
- Benjamin HawleyWichita$2K
- Kyle SmothersWichita$2K
- Matthew StumpeWichita$2K
- Randall RegehrWichita$1K
- Dennis ThakorWichita$860
- Aaron ThiessenWichita$558
- Hinrich StaeckerKansas City$499K
- Stanley McClurgMerriam$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.